Cargando…

Frailty in Patients with Cardiovascular Disease: Why, When, and How to Measure

Frailty is a geriatric syndrome of impaired resistance to stressors due to a decline in physiologic reserve. Frailty and cardiovascular disease (CVD) share a common biological pathway, and CVD may accelerate the development of frailty. Frailty is identified in 25% to 50% of patients with CVD, depend...

Descripción completa

Detalles Bibliográficos
Autor principal: Afilalo, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Current Science Inc. 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165117/
https://www.ncbi.nlm.nih.gov/pubmed/21949560
http://dx.doi.org/10.1007/s12170-011-0186-0
_version_ 1782211088384786432
author Afilalo, Jonathan
author_facet Afilalo, Jonathan
author_sort Afilalo, Jonathan
collection PubMed
description Frailty is a geriatric syndrome of impaired resistance to stressors due to a decline in physiologic reserve. Frailty and cardiovascular disease (CVD) share a common biological pathway, and CVD may accelerate the development of frailty. Frailty is identified in 25% to 50% of patients with CVD, depending on the frailty scale used and the population studied. Frail patients with CVD, especially those undergoing invasive procedures or suffering from coronary artery disease and heart failure, are more likely to suffer adverse outcomes as compared to their non-frail counterparts. Five-meter gait speed is a simple and effective way of objectively measuring frailty in patients with CVD and should be incorporated in risk assessment.
format Online
Article
Text
id pubmed-3165117
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Current Science Inc.
record_format MEDLINE/PubMed
spelling pubmed-31651172011-09-21 Frailty in Patients with Cardiovascular Disease: Why, When, and How to Measure Afilalo, Jonathan Curr Cardiovasc Risk Rep Article Frailty is a geriatric syndrome of impaired resistance to stressors due to a decline in physiologic reserve. Frailty and cardiovascular disease (CVD) share a common biological pathway, and CVD may accelerate the development of frailty. Frailty is identified in 25% to 50% of patients with CVD, depending on the frailty scale used and the population studied. Frail patients with CVD, especially those undergoing invasive procedures or suffering from coronary artery disease and heart failure, are more likely to suffer adverse outcomes as compared to their non-frail counterparts. Five-meter gait speed is a simple and effective way of objectively measuring frailty in patients with CVD and should be incorporated in risk assessment. Current Science Inc. 2011-08-02 2011 /pmc/articles/PMC3165117/ /pubmed/21949560 http://dx.doi.org/10.1007/s12170-011-0186-0 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
Afilalo, Jonathan
Frailty in Patients with Cardiovascular Disease: Why, When, and How to Measure
title Frailty in Patients with Cardiovascular Disease: Why, When, and How to Measure
title_full Frailty in Patients with Cardiovascular Disease: Why, When, and How to Measure
title_fullStr Frailty in Patients with Cardiovascular Disease: Why, When, and How to Measure
title_full_unstemmed Frailty in Patients with Cardiovascular Disease: Why, When, and How to Measure
title_short Frailty in Patients with Cardiovascular Disease: Why, When, and How to Measure
title_sort frailty in patients with cardiovascular disease: why, when, and how to measure
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165117/
https://www.ncbi.nlm.nih.gov/pubmed/21949560
http://dx.doi.org/10.1007/s12170-011-0186-0
work_keys_str_mv AT afilalojonathan frailtyinpatientswithcardiovasculardiseasewhywhenandhowtomeasure